Treating Gastrointestinal and Autism Symptoms in Adults with Autism using Microbiota Transfer Therapy (MTT)

Abstract

Purpose: The purpose of this study is to determine the safety and efficacy of Microbiota Transfer Therapy for adults with autism and chronic gastrointestinal problems. Scope: The scope of the project is a randomized, double-blind, placebo-controlled trial of MTT for 84 adults with autism. The trial also includes an extension, partial cross-over, and long-term follow-up (6, 12, and 18 months). It includes extensive evaluation of autism-related and gastrointestinal symptoms, evaluation of microbiome composition, and blood safety tests. It includes 84 neurotypical controls (half with GI symptoms, half without) for comparison of baseline microbiota (no treatment for the neurotypical group).Major findings: none to report yet.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Sep 01, 2021
Accession Number
AD1154868

Entities

People

  • James B. Adams
  • Richard E Frye
  • Rosa Krajmalnik-brown

Organizations

  • Arizona State University

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Abstracts
  • Acquisition
  • Biomedical Research
  • Blood Counts
  • Clinical Trials
  • Covid-19
  • Department Of Defense
  • Health Services
  • Medical Personnel
  • Microbiomes
  • Patent Applications
  • Physicians
  • Procurement
  • Professional Development
  • Research Facilities
  • Sars
  • Standards
  • Technology Transfer
  • Test And Evaluation
  • Universities
  • Viruses

Fields of Study

  • Medicine
  • Psychology

Readers

  • Child and Adolescent Substance Abuse Science in Autism Spectrum Disorders.
  • Gulf War Illness and Chronic Multisymptom Illness in Veterans.
  • Software Engineering